Table: begin end state 1 31 cytoplasmic 32 53 transmembrane 54 58 non-cytoplasmic 59 84 transmembrane 85 117 cytoplasmic 118 144 transmembrane 145 150 non-cytoplasmic 151 168 transmembrane 169 179 cytoplasmic 180 200 transmembrane 201 224 non-cytoplasmic 225 243 transmembrane 244 254 cytoplasmic 255 278 transmembrane 279 300 non-cytoplasmic 301 327 transmembrane 328 352 cytoplasmic 353 372 transmembrane 373 377 non-cytoplasmic 378 400 transmembrane 401 418 cytoplasmic 419 435 transmembrane 436 440 non-cytoplasmic 441 459 transmembrane 460 470 cytoplasmic 471 491 transmembrane 492 497 non-cytoplasmic
Input: >AO353_20050 MATHVHGTQPTIPGISPRPAAGSLRQLEPRRLSLSLLIALVVGSMIGSGIFSLPQNMAAG AGAGAILIGWLITGVGMLSLALVYQTLSNRQPELDNGVFAYARALGGEFLGFNSAWGYWI SAWIGNVSYLVILFAALSYFFPLFGEGNNKAAIAAASLVLWSLHWMILRGMRTAARANAL TTLAKIVPLLLFIGLVIAAFQRETFMVDFWGAPALGSTLDQVKSTMLVTVWVFIGIEGAN VFSARAAERVNVGRATVIGFVLTLLLLIAVSLLSLGILRQPELAALKNPSMSGVLEAVAG PWGAMLISVGLIISVGGALLAWTLLAAESVFTPAKEKVMPGPLALENTHGAPANALWITN GCIQLFLLLTLYSSASYLALISLATSMILLPYLFSGLYALKLTWQGATYAGHKALQLRDM AIASVATLYCLWLLFAAGPKYMLLSALLYAPGSLIYLATKRARQGQALNGFEWGLLIVIW AAAAFAGWMLWSGKLAL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server